BetterLife Pharma Stock

BetterLife Pharma EBIT

The EBIT of BetterLife Pharma (BETR.CN) as of Aug 14, 2026 is -1.81 M CAD. In the previous year, EBIT was -4.72 M CAD — a change of -61.72% (higher).

EBIT

-1.81 MCAD

YoY

-61.72%

Last updated:

In 2026, BetterLife Pharma's EBIT was -1.81 M CAD, a -61.72% increase from the -4.72 M CAD EBIT recorded in the previous year.

The BetterLife Pharma EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M CAD)
Date
EBIT (M CAD)
Jan 1, 2019
-6.46 base
Jan 1, 2020
-9.20 base
Jan 1, 2021
-7.95 base
Jan 1, 2022
-9.97 base
Jan 1, 2023
-9.26 base
Jan 1, 2024
-3.21 base
Jan 1, 2025
-4.72 base
Jan 1, 2026
-1.81 base
YEAREBIT (M CAD)
2026 -1.81
2025 -4.72
2024 -3.21
2023 -9.26
2022 -9.97
2021 -7.95
2020 -9.20
2019 -6.46
2018 -1.16
2017 -
2016 8.60
2015 2.11
2014 -10.10
2013 -0.09
2012 -0.36
Access this data via the Eulerpool API

BetterLife Pharma Revenue

BetterLife Pharma Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
0.00 CAD
-6.46 M CAD
-9.15 M CAD
Jan 1, 2020
0.00 CAD
-9.20 M CAD
-19.59 M CAD
Jan 1, 2021
0.00 CAD
-7.95 M CAD
-36.35 M CAD
Jan 1, 2022
0.00 CAD
-9.97 M CAD
-12.16 M CAD
Jan 1, 2023
0.00 CAD
-9.26 M CAD
-9.02 M CAD
Jan 1, 2024
0.00 CAD
-3.21 M CAD
-2.89 M CAD
Jan 1, 2025
0.00 CAD
-4.72 M CAD
-3.52 M CAD
Jan 1, 2026
0.00 CAD
-1.81 M CAD
-1.50 M CAD

BetterLife Pharma Margins

BetterLife Pharma stock margins

The BetterLife Pharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BetterLife Pharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BetterLife Pharma.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
0.00 %
- %
- %
Jan 1, 2020
0.00 %
- %
- %
Jan 1, 2021
0.00 %
- %
- %
Jan 1, 2022
0.00 %
- %
- %
Jan 1, 2023
0.00 %
- %
- %
Jan 1, 2024
0.00 %
- %
- %
Jan 1, 2025
0.00 %
- %
- %
Jan 1, 2026
0.00 %
- %
- %

BetterLife Pharma Stock analysis

What does BetterLife Pharma do? BetterLife Pharma Inc is an innovative company specializing in the development and marketing of therapeutic solutions. The company was founded in 2016 and is headquartered in Vancouver, Canada. It is a publicly traded company listed on the Canadian stock exchange TSX Venture Exchange under the ticker symbol BETR and on the Frankfurt stock exchange under the ticker symbol NPA. BetterLife's mission is to research and develop life-changing medications that improve patients' lives while increasing shareholder value. The company relies on a combination of scientific knowledge and innovative technology to develop effective and safe therapies. BetterLife Pharma is divided into the biotechnology and healthcare sectors. In biotechnology research, the company focuses on developing novel medications for the treatment of conditions such as depression, anxiety, pain, and autoimmune diseases. In healthcare, the company offers a range of services including clinical trials and consulting for healthcare organizations and companies. An important product of BetterLife is the medication TD-0148A, which is developed for the treatment of depression. It aims to regulate neurotransmitters in the brain to improve the mood of depressive patients. The medication is currently in clinical phase II and has the potential to be used by millions of patients worldwide. Another important product of BetterLife is the platform technology Cyclica, which allows companies and researchers to make better predictions about drug effects. Cyclica utilizes artificial intelligence and machine learning to gather and analyze a wide range of information about drugs and their mechanisms of action. The technology has already gained global recognition and is used by prestigious institutions such as Harvard Medical School. BetterLife's business model is based on collaboration with other companies, researchers, and healthcare experts. The company aims to form partnerships with companies in the biotech and pharmaceutical industries to further develop and market its technologies and products. In recent years, BetterLife Pharma Inc has made significant progress and achieved impressive milestones. The company has conducted several successful financing rounds to fund its research and development. It has formed strategic alliances with key players in the industry and promoted its technologies and products worldwide. BetterLife Pharma represents innovation, excellence, and excellence in research and development. The company has the potential to improve the lives of millions of people worldwide while providing attractive returns for its investors. BetterLife Pharma is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing BetterLife Pharma's EBIT

BetterLife Pharma's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of BetterLife Pharma's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

BetterLife Pharma's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in BetterLife Pharma’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about BetterLife Pharma stock

EBIT of BetterLife Pharma is -1.81 M CAD in 2026.

EBIT of BetterLife Pharma changed from -4.72 M CAD to -1.81 M CAD, representing a -61.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT BetterLife Pharma since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's BetterLife Pharma historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — BetterLife Pharma

All Key Metrics — BetterLife Pharma